eISSN: 2449-9315
ISSN: 1234-8279
Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
2/2020
vol. 36
 
Share:
Share:
abstract:
Case report

New psychopharmacotherapy dilemmas associated with COVID-19 – case report

Jolanta Kucharska-Mazur
1
,
Jędrzej Stańczak
1
,
Jerzy Samochowiec
1

  1. Department of Psychiatry, Pomeranian Medical University in Szczecin
Farmakoterapia w Psychiatrii i Neurologii 2020, 36 (2), 149–153
Online publish date: 2021/12/06
View full text Get citation
 
Case study
Due to the current pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), it is necessary to take therapeutic decisions con cerning the simultaneous use of psychopharmacology and drugs supporting the elimination of the virus, es pecially chloroquine.

Opis przypadku
A 36-year-old female patient, with a diag nosis of paranoid schizophrenia, treated with clozapine, zuclopenthixol and lamotrigine, was diagnosed with SARS-CoV-2 infection. Following the recommendations of a specialist of infectious diseases, azithromycin and chloroquine were introduced to the treatment. Due to po tential drug interactions, morphology, AST, ALT and ECG were monitored. No abnormalities of monitored parame ters were observed. The virus was effectively eliminated.

Comments
With appropriate patient monitoring and care, antipsychotics were successfully combined with chloroquine and azithromycin in short-term therapy of lung inflammatory changes associated with SARS-CoV-2 infection.

keywords:

antipsychotics, chlorochina, SARS-CoV-2


Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.